Psychiatry and Behavioral Health

Latest News

FDA Approves Extended-Release Therapy for Major Depression
FDA Approves Extended-Release Therapy for Major Depression

September 28th 2023

Exxua is approved to treat adults with major depressive disorder, but its labeling does not contain warnings about sexual function or weight gain.

FDA Accepts NDA for Zuranolone for Depression
FDA Accepts NDA for Zuranolone for Depression

February 6th 2023

FDA Approves Vraylar for Major Depressive Disorder
FDA Approves Vraylar for Major Depressive Disorder

December 20th 2022

EmpiRx Health Lowers Drug Spend in Mental Health
EmpiRx Health Lowers Drug Spend in Mental Health

October 7th 2022

FDA Accepts NDA for Longer-Acting Aripiprazole
FDA Accepts NDA for Longer-Acting Aripiprazole

September 14th 2022

More News

© 2023 MJH Life Sciences

All rights reserved.